---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-025805"
form_type: "8-K"
ticker: "SSII"
cik: "0001676163"
company_name: "SS Innovations International, Inc."
filed_at: "2025-03-31T23:59:59+00:00"
generated_at: "2026-05-24T01:55:09.890814+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# SS Innovations reports ~$22M preliminary 2024 revenue, almost 4x YoY; Q1 2025 est $6.4M

## Summary
- Preliminary 2024 revenue ~$22M (unaudited), up from ~$5.5M in 2023; gross margin improved to 36.9% from 12.3%.
- Q1 2025 estimated revenue ~$6.4M with ~45% gross margin; installations rose from 64 to 78 systems.
- SSi Mantra systems installed at 75 hospitals; performed 3,500+ surgeries with zero device-related mortality.
- Expects FDA & CE approvals by end of 2025/early 2026; also received CDSCO approval for telesurgery in India.
- Appointed independent directors Tim Adams and Dr. Frederic Moll (founder of Intuitive Surgical) to board.

## SEC filing metadata
- accession: 0001213900-25-025805
- form_type: 8-K
- ticker: SSII
- cik: 0001676163
- company_name: SS Innovations International, Inc.
- filed_at: 2025-03-31T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676163/000121390025025805/0001213900-25-025805-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676163/000121390025025805/ea0236284-8k_ssinno.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-025805
- JSON: https://secwatch.observer/filing/0001213900-25-025805.json
- Plain text: https://secwatch.observer/filing/0001213900-25-025805.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.